PubMed

Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines.

Troester MA, Hoadley KA, Parker JS, Perou CM.

Environ Health Perspect. 2004 Nov;112(16):1607-13.PMID: 15598611 [PubMed - indexed for MEDLINE]Related articlesFree article

Cell-type-specific responses to chemotherapeutics in breast cancer.

Troester MA, Hoadley KA, Sørlie T, Herbert BS, Børresen-Dale AL, Lønning PE, Shay JW, Kaufmann WK, Perou CM.

Cancer Res. 2004 Jun 15;64(12):4218-26.PMID: 15205334 [PubMed - indexed for MEDLINE]Related articlesFree article

cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.

Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM.

Breast Cancer Res Treat. 2006 Mar;96(1):17-39. Epub 2005 Dec 2.PMID: 16322897 [PubMed - indexed for MEDLINE]Related articles

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.

Györffy B, Serra V, Jürchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schäfer R.

Oncogene. 2005 Nov 17;24(51):7542-51.PMID: 16044152 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

Zentralbl Gynakol. 2006 Apr;128(2):76-81.PMID: 16673249 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance.

Hernández-Vargas H, Rodríguez-Pinilla SM, Julián-Tendero M, Sánchez-Rovira P, Cuevas C, Antón A, Ríos MJ, Palacios J, Moreno-Bueno G.

Breast Cancer Res Treat. 2007 Apr;102(2):157-72. Epub 2006 Oct 13.PMID: 17039268 [PubMed - indexed for MEDLINE]Related articles

Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.

Fricke E, Hermannstädter C, Keller G, Fuchs M, Brunner I, Busch R, Höfler H, Becker KF, Luber B.

Oncology. 2004;66(2):150-9.PMID: 15138368 [PubMed - indexed for MEDLINE]Related articles

Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.

Kurokawa Y, Matoba R, Nagano H, Sakon M, Takemasa I, Nakamori S, Dono K, Umeshita K, Ueno N, Ishii S, Kato K, Monden M.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6029-38.PMID: 15447987 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression patterns associated with p53 status in breast cancer.

Troester MA, Herschkowitz JI, Oh DS, He X, Hoadley KA, Barbier CS, Perou CM.

BMC Cancer. 2006 Dec 6;6:276.PMID: 17150101 [PubMed - indexed for MEDLINE]Related articlesFree article

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, Becette V, Farmer P, André S, Acharya CR, Mukherjee S, Cameron D, Bergh J, Nevins JR, Iggo RD.

Lancet Oncol. 2007 Dec;8(12):1071-8. Epub 2007 Nov 19.PMID: 18024211 [PubMed - indexed for MEDLINE]Related articles

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.

Zoli W, Ulivi P, Tesei A, Fabbri F, Rosetti M, Maltoni R, Giunchi DC, Ricotti L, Brigliadori G, Vannini I, Amadori D.

Breast Cancer Res. 2005;7(5):R681-9. Epub 2005 Jun 22.PMID: 16168113 [PubMed - indexed for MEDLINE]Related articlesFree article

Breast cancer molecular subtypes respond differently to preoperative chemotherapy.

Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN, Pusztai L.

Clin Cancer Res. 2005 Aug 15;11(16):5678-85.PMID: 16115903 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan) (AC) response and resistance.

Cleator S, Tsimelzon A, Ashworth A, Dowsett M, Dexter T, Powles T, Hilsenbeck S, Wong H, Osborne CK, O'Connell P, Chang JC.

Breast Cancer Res Treat. 2006 Feb;95(3):229-33.PMID: 16322899 [PubMed - indexed for MEDLINE]Related articles

DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.

Menendez JA, Vellon L, Lupu R.

Int J Mol Med. 2006 Dec;18(6):1081-7.PMID: 17089011 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.

Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, O'Connell P.

Lancet. 2003 Aug 2;362(9381):362-9.PMID: 12907009 [PubMed - indexed for MEDLINE]Related articles

Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy.

Engles JM, Quarless SA, Mambo E, Ishimori T, Cho SY, Wahl RL.

J Nucl Med. 2006 Apr;47(4):603-8.PMID: 16595493 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.

Folgueira MA, Carraro DM, Brentani H, Patrão DF, Barbosa EM, Netto MM, Caldeira JR, Katayama ML, Soares FA, Oliveira CT, Reis LF, Kaiano JH, Camargo LP, Vêncio RZ, Snitcovsky IM, Makdissi FB, e Silva PJ, Góes JC, Brentani MM.

Clin Cancer Res. 2005 Oct 15;11(20):7434-43.PMID: 16243817 [PubMed - indexed for MEDLINE]Related articlesFree article

Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells.

Atienza JM, Roth RB, Rosette C, Smylie KJ, Kammerer S, Rehbock J, Ekblom J, Denissenko MF.

Mol Cancer Ther. 2005 Mar;4(3):361-8.PMID: 15767545 [PubMed - indexed for MEDLINE]Related articlesFree article

Template for toxicants: gene expression varies by cell type.

Barrett JR.

Environ Health Perspect. 2004 Nov;112(16):A944. No abstract available. PMID: 15598609 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.

De Angelis PM, Kravik KL, Tunheim SH, Haug T, Reichelt WH.

Mol Cancer. 2004 Apr 26;3:11.PMID: 15109396 [PubMed - indexed for MEDLINE]Related articlesFree article